Research theme for competitive and other funds (3)：
2019 - 2022 オピオイド使用高齢がん患者における抗コリン性副作用発現と医薬品との関連解析
2016 - 2019 Basic study of the possibility of newly synthesized 3-styrylchromone derivatives as therapeutic drugs for oral cancer
2015 - 2018 Adverse Reactions to Potent Opioids: An analysis using the largescale Japanese Adverse Drug Event Report database
Papers (20)：
Junko Nagai, Yoichi Ishikawa. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database. PLOS ONE. 2021
Koichi Takao, Yuri Takemura, Junko Nagai, Hitoshi Kamauchi, Kaori Hoshi, Ryo Mabashi, Yoshihiro Uesawa, Yoshiaki Sugita. Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors. Bioorganic & medicinal chemistry. 2021. 42. 116255-116255
Yusuke Kan, Junko Nagai, Yoshihiro Uesawa. Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database. Scientific reports. 2021. 11. 1. 9625-9625
Michito Teratani, Shouta Nakamura, Hiroshi Sakagami, Masakazu Fujise, Masashi Hashimoto, Noriyuki Okudaira, Kenjiro Bandow, Yosuke Iijima, Junko Nagai, Yoshihiro Uesawa, et al. Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro. Anticancer research. 2020. 40. 9. 4885-4894
Yoshiaki Sugita, Koichi Takao, Yoshihiro Uesawa, Junko Nagai, Yosuke Iijima, Motohiko Sano, Hiroshi Sakagami. Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma. Medicines (Basel, Switzerland). 2020. 7. 9. 50-50
